Learn About CAR-T（Chimeric Antigen Receptor T-cell）

Chimeric antigen receptor (CAR)-T cell therapy is a progressive new pillar in immune cell therapy for cancer, offering hope to many patients. In CAR-T-cell therapies, T cells are taken from the patient's blood and are changed in the lab by adding a gene for a receptor (called a chimeric antigen receptor or CAR), which helps the T cells attach to a specific cancer cell antigen. The CAR-T cells are then given back to the patient.

This handbook will introduce you to the main components, manufacturing process and prospects of this promising immunotherapy.We will also provide detailed information about potential adverse reactions and corresponding management methods, assisting you in better coping with discomfort and complications during the treatment process.

Please note that this handbook serves as a reference only and cannot replace personalized advice and treatment plans provided by doctors or healthcare professionals. CAR-T therapy is a highly individualized treatment technique, and thus each patient undergoes rigorous evaluation and screening before treatment. If you have any health concerns or questions, please consult a doctor or contact our medical team for the most suitable advice and guidance.